Altus Pharmaceuticals

Biotechnology

United States, Ohio

$50M to $100M

51-200

Hound Labs

Biotechnology

United States, California

$50M to $100M

51-200

La Jolla Pharmaceutical Company

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Target RWE

Biotechnology

United States, North Carolina

$50M to $100M

51-200

Voyager Therapeutics

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Frontier Scientific

Biotechnology

United States, Delaware

$50M to $100M

51-200

LFB USA

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Sepax Technologies

Biotechnology

United States, Delaware

$50M to $100M

51-200

Navigate BioPharma Services

Biotechnology

United States, California

$50M to $100M

51-200

Kriya Therapeutics

Biotechnology

United States, California

$50M to $100M

51-200

Maryland Psychiatric Research Center

Biotechnology

United States, Maryland

$50M to $100M

51-200

Viridos

Biotechnology

United States, California

$50M to $100M

51-200

REPROCELL

Biotechnology

United States, Indiana

$50M to $100M

51-200

Receptos, a wholly-owned subsidiary of Celgene

Biotechnology

United States, California

$50M to $100M

51-200

Evogene

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Fluid Metering

Biotechnology

United States, New York

$50M to $100M

51-200

DNA GTx LAB

Biotechnology

United States, Minnesota

$50M to $100M

51-200

Henlius USA

Biotechnology

United States, California

$50M to $100M

51-200

Aitia

Biotechnology

United States, Massachusetts

$50M to $100M

51-200

Bridge to Life

Biotechnology

United States, Illinois

$50M to $100M

51-200